LLINS Tech

Bring medical devices into global markets with more clarity and control

Since 2017, LLINS Tech has supported medical device and IVD companies with regulatory strategy, dossier readiness, authorized representative services, quality systems, and clinical evidence planning across China, the EU, the US, and other target markets.

  • CE / MDR / IVDR
  • FDA / 510(k) / De Novo
  • NMPA registration support
  • Authorized representatives

Engagement Snapshot

01

Route design before execution

We start by clarifying market priorities, product classification, evidence gaps, and timing risk.

02

Dossier and compliance readiness

Technical documentation, testing, clinical rationale, and quality requirements are aligned as one track.

03

Cross-market coordination

China, EU, US, and representative services are handled with continuity instead of isolated handoffs.

2017 focused on medical device regulatory and market access work
10+ years average industry and regulatory experience across the team
China / EU / US multi-market coordination for regulatory execution
Representative + QMS compliance setup and long-tail maintenance considered together

Core Services

Six high-frequency service areas, connected through one execution model

Instead of splitting regulatory work into isolated tasks, LLINS Tech combines strategy, dossier support, quality systems, and representative services into a more coherent delivery flow.

See the full service structure

Global Regulatory Strategy

Build a clearer route based on target markets, classification, evidence requirements, and business priorities.

EU Market Access

Support MDR / IVDR readiness, CE documentation, testing plans, clinical alignment, and EU representative coordination.

US Market Access

Support FDA pathway assessment, 510(k) preparation, QSR alignment, and US representative service requirements.

China Registration Support

Coordinate NMPA submission readiness, innovative product strategy, and local evidence expectations.

Quality Systems & Technical Documentation

Connect ISO 13485, MDSAP, and QSR expectations with the documentation work needed for approvals.

Clinical & Testing Coordination

Support performance studies, clinical evaluation logic, overseas testing coordination, and evidence packaging.

Delivery Model

See the route clearly before accelerating the work

Speed matters in regulatory programs, but speed on the wrong route creates more waste. The delivery model is designed to reduce that risk early.

01

Assess the current state

Review target markets, classification, existing evidence, testing gaps, and quality system maturity.

02

Design the market-entry route

Set priorities, key deliverables, representative needs, and realistic milestones for the program.

03

Organize documentation and support resources

Link technical files, testing work, clinical evidence, and quality actions into one coordinated timeline.

04

Submit, maintain, and extend

Prepare for submission, post-market obligations, representative support, and future market expansion.

Operating Footprint

China-based coordination with connections into Europe, the US, and overseas support resources

Public company information shows operating contacts in Shanghai and Hangzhou, together with links to representative resources in Germany, the UK, the US, and overseas testing collaboration.

Learn how LLINS Tech works

Office and contact points

  • Shanghai Room 1115, Building A, Xuhui Vanke Center, No.55 Ding'an Road
  • Hangzhou Room 1012, Tianheng Building, 1509 Binsheng Road, Binjiang District
  • Overseas coordination Germany, UK, US representative resources and testing partners

Best fit engagements

  • First-time entry into the EU or US market and the route still needs to be defined
  • Existing technical documents are available, but cross-market mapping is inefficient
  • Representative services, QMS work, and registration preparation need one coordinated operating layer

Contact

If a market program is already in motion, start with a route conversation

A short first discussion can align the target market, device class, timing constraints, and dossier readiness.

Start With Clarity

Clarify the market, the route, and what evidence still needs work before the schedule tightens.

Send an inquiry